Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature clinical trials

1 of 1 indexed Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature: 1 US clinical trial tracked, 1 recruiting.

Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Boston Children's Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition progressive-epilepsy-andor-ataxia-with-myoclonus-as-a-major-feature

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Progressive Epilepsy and (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature

Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

US sites by state

Facility locations filed on Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature trials. A trial with sites in several states counts in each.

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Boston Children's Hospital sponsors the most Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature trials on record, review their full trial history before evaluating a specific study. See Boston Children's Hospital's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature condition card totals 1 registered trials; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.